Dimensional Fund Advisors
RLAY icon

Dimensional Fund Advisors’s Relay Therapeutics RLAY Stock Holding History

Dimensional Fund Advisors’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$58.5M Buy
3,127,564
+187,028
+6% +$2.72M 0.01% 1512
2026
Q1 		$29.2M Buy
2,940,536
+460,186
+19% +$4.12M 0.01% 1780
2025
Q4 		$21M Sell
2,480,350
-2,600
-0.1% -$18.6K ﹤0.01% 1942
2025
Q3 		$13M Sell
2,482,950
-306,510
-11% -$1.17M ﹤0.01% 2202
2025
Q2 		$9.65M Sell
2,789,460
-9,631
-0.3% -$28.6K ﹤0.01% 2287
2025
Q1 		$7.33M Sell
2,799,091
-165,906
-6% -$650K ﹤0.01% 2372
2024
Q4 		$12.2M Buy
2,964,997
+1,216,334
+70% +$6.62M ﹤0.01% 2224
2024
Q3 		$12.4M Buy
1,748,663
+228,323
+15% +$1.71M ﹤0.01% 2211
2024
Q2 		$9.91M Sell
1,520,340
-80,474
-5% -$550K ﹤0.01% 2265
2024
Q1 		$13.3M Buy
1,600,814
+241,659
+18% +$2.36M ﹤0.01% 2189
2023
Q4 		$15M Buy
1,359,155
+341,487
+34% +$2.88M ﹤0.01% 2128
2023
Q3 		$8.56M Sell
1,017,668
-146,718
-13% -$1.58M ﹤0.01% 2338
2023
Q2 		$14.6M Sell
1,164,386
-71,409
-6% -$888K ﹤0.01% 2082
2023
Q1 		$20.4M Buy
+1,235,795
New +$22.2M 0.01% 1900
2022
Q3 		$14.2M Buy
635,607
+241,816
+61% +$5.31M 0.01% 2004
2022
Q2 		$6.59M Buy
393,791
+335,925
+581% +$7.2M ﹤0.01% 2368
2022
Q1 		$1.73M Buy
+57,866
New +$1.4M ﹤0.01% 2869
2021
Q3 		– Sell
-6,236
Closed -$228K – 3527
2021
Q2 		$228K Hold
6,236
– – ﹤0.01% 3313
2021
Q1 		$216K Buy
+6,236
New +$271K ﹤0.01% 3278

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Dimensional Fund Advisors's RLAY Position: Q2 2026 in Review

Dimensional Fund Advisors increased its Relay Therapeutics (RLAY) stake by 6.4% in Q2 2026, buying an estimated $2.72M and bringing the position to 3,127,564 shares worth $58.5M. The position accounts for 0.01% of the portfolio, ranked #1512.

Dimensional Fund Advisors first reported a position in RLAY in Q1 2021 and has held it in 19 quarters since. 258 funds tracked by Wall St. Rank hold RLAY as of Q2 2026.

  • Dimensional Fund Advisors held 3,127,564 shares of Relay Therapeutics worth $58.5M as of Q2 2026.
  • Dimensional Fund Advisors bought 187,028 Relay Therapeutics shares in Q2 2026, an estimated $2.72M.
  • Relay Therapeutics made up 0.01% of Dimensional Fund Advisors's portfolio in Q2 2026, its #1512 holding.
  • Dimensional Fund Advisors first reported a position in Relay Therapeutics in Q1 2021 and has held it in 19 quarters since.
  • 258 funds tracked by Wall St. Rank held Relay Therapeutics as of Q2 2026.

Based on Dimensional Fund Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.